Page last updated: 2024-09-05

erlotinib hydrochloride and Hyponatremia

erlotinib hydrochloride has been researched along with Hyponatremia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bortlicek, Z; Bruha, F; Fiala, O; Minarik, M; Mukensnabl, P; Pesek, M; Racek, J; Svaton, M	1
Butler, JS; Donahue, BR; Huang, Y; Olmez, I; Rubin, P; Xu, Y	1

Other Studies

2 other study(ies) available for erlotinib hydrochloride and Hyponatremia

Article	Year
Predictive and prognostic significance of sodium levels in patients with NSCLC treated by erlotinib. Anticancer research, 2014, Volume: 34, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Hyponatremia; Lung Neoplasms; Male; Middle Aged; Proportional Hazards Models; Protein Kinase Inhibitors; Quinazolines; Retrospective Studies; Sodium; Treatment Outcome	2014
Clinical outcomes in extracranial tumor sites and unusual toxicities with concurrent whole brain radiation (WBRT) and Erlotinib treatment in patients with non-small cell lung cancer (NSCLC) with brain metastasis. Lung cancer (Amsterdam, Netherlands), 2010, Volume: 70, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Disease Progression; Drug Interactions; Erlotinib Hydrochloride; Female; Humans; Hyponatremia; Lung Neoplasms; Male; Middle Aged; Neutropenia; Quinazolines; Treatment Outcome; Whole-Body Irradiation	2010

Article

Year

Predictive and prognostic significance of sodium levels in patients with NSCLC treated by erlotinib.

Anticancer research, 2014, Volume: 34, Issue:12

Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Hyponatremia; Lung Neoplasms; Male; Middle Aged; Proportional Hazards Models; Protein Kinase Inhibitors; Quinazolines; Retrospective Studies; Sodium; Treatment Outcome

2014

Clinical outcomes in extracranial tumor sites and unusual toxicities with concurrent whole brain radiation (WBRT) and Erlotinib treatment in patients with non-small cell lung cancer (NSCLC) with brain metastasis.

Lung cancer (Amsterdam, Netherlands), 2010, Volume: 70, Issue:2

Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Disease Progression; Drug Interactions; Erlotinib Hydrochloride; Female; Humans; Hyponatremia; Lung Neoplasms; Male; Middle Aged; Neutropenia; Quinazolines; Treatment Outcome; Whole-Body Irradiation

2010